Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non–Small Cell Lung Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non–Small Cell Lung Adenocarcinoma

Published:2017-10 Issue:10 Volume:12 Page:e165-e167
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Dall’Olio Filippo Gustavo,Ruatta Celeste,Melotti Barbara,Sperandi Francesca,Ciardella Antonio Pasquale,Ardizzoni Andrea

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference5 articles.

1. Uveal metastasis from lung cancer: clinical features, treatment, and outcome in 194 patients;Shah;Ophthalmology,2014

2. Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer;Mok;N Engl J Med,2017

3. Management of choroidal metastases;Jardel;Cancer Treat Rev,2014

4. Treatment of choice for patients with EGFR mutation-positive non-small cell lung carcinoma presenting with choroidal metastases: radiotherapy or TKIs?;Maskell;Can J Ophthalmol,2017

5. Tyrosine kinase inhibitors in the treatment of choroidal metastases from non-small-cell lung cancer: a case report and review of literature;Nair;Ocul Oncol Pathol,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR-mutated lung adenocarcinoma with choroidal oligometastasis during treatment with gefitinib: a case report;International Cancer Conference Journal;2024-03-06

2. Posterior segment manifestations of ocular metastasis;Current Opinion in Ophthalmology;2023-08-09

3. Effect of the First-Line Therapy with Osimertinib for a Metastatic Choroidal Tumor in Advanced-Stage Lung Cancer: A Case Report;Case Reports in Ophthalmology;2023-07-13

4. Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer;American Journal of Ophthalmology Case Reports;2022-06

5. Delayed Diagnosis of Lung Carcinoma Presenting as Choroidal Metastasis in a COVID-19 Patient and Initially Treated with Osimertinib;Klinische Monatsblätter für Augenheilkunde;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3